Ironwood receives Nasdaq deficiency notice for bid price below $1.00; has until Nov 24, 2025 to regain compliance

IRONWOOD PHARMACEUTICALS INC

Received deficiency letter on May 28, 2025 for bid price below $1.00 for 30 consecutive business days.
Compliance period of 180 calendar days, until November 24, 2025, to regain minimum bid price.
To cure, bid price must close at $1.00 or more for at least 10 consecutive business days.
If not compliant by deadline, company may qualify for additional 180 days by moving to Nasdaq Capital Market.
No immediate effect on listing; company monitoring options but cannot assure compliance.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.